Kidney aging--inevitable or preventable? (Q37913979)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826079%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Devasmita Choudhury

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826079%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

English

0 references

publication date

9 August 2011

1 reference

Nature Reviews Nephrology

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826079%20AND%20SRC:MED&resulttype=core&format=json

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826079%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826079%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

706-717

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826079%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

12

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2011.104

9 February 2020

exact match

0 references

cites work

The Effect of Age on Creatinine Clearance in Men: A Cross-sectional and Longitudinal Study

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Glucose tolerance and age-associated decline in renal function of hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

The association between age and nephrosclerosis on renal biopsy among healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Longitudinal studies on the rate of decline in renal function with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Vascular remodeling of the carotid artery in patients with untreated essential hypertension increases with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Angiotensin-converting enzyme and vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Neointimal-specific induction of apoptosis by losartan results in regression of vascular lesion in rat aorta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Blood pressure in children and target-organ damage later in life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Accelerated senescence in kidneys of low-birth-weight rats after catch-up growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Nephron number, renal function, and arterial pressure in aged GDNF heterozygous mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Histopathological evidence of poor prognosis in patients with vesicoureteral reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Long-term follow-up of kidney donors: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Hypertensive nephrosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Changes in nitric oxide precursor, L-arginine, and metabolites, nitrate and nitrite, with aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Effects of aging on glomerular function and number in living kidney donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Acute kidney injury increases risk of ESRD among elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Acute kidney injury: a springboard for progression in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Chronic dialysis and death among survivors of acute kidney injury requiring dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Occult impaired glucose regulation in patients with atherosclerosis is associated to the number of affected vascular districts and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Relation between C-reactive protein, homocysteine levels, fibrinogen, and lipoprotein levels and leukocyte and platelet counts, and 10-year risk for cardiovascular disease among healthy adults in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Aberrant mitochondrial homeostasis in the skeletal muscle of sedentary older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Association between chronic dental infection and acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Chronic inflammation potentiates kidney aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Age and cystatin C in healthy adults: a collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Obesity and change in estimated GFR among older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Kidney pathological changes in metabolic syndrome: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Obesity and insulin resistance as risk factors for chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Metabolic syndrome and kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

The metabolic syndrome and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Angiotensin II: a powerful controller of sodium transport in the early proximal tubule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Effects of aging on the renal glomerulus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Interactions between renin angiotensin system and advanced glycation in the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Protective effect of the inhibition of the renin-angiotensin system on aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Sustained tubulo-interstitial protection in SHRs by transient losartan treatment: an effect of decelerated aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Variation of intrarenal angiotensin II and angiotensin II receptors by acute renal ischemia in the aged rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Tubular cell senescence and expression of TGF-beta1 and p21(WAF1/CIP1) in tubulointerstitial fibrosis of aging rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Live longer sans the AT1A receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

TGF-beta: regulation of extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Relaxin and the progression of kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

eNOS, metabolic syndrome and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Molecular mechanisms of angiotensin II in the kidney: emerging role in the progression of renal disease: beyond haemodynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of re

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Oxidant stress leads to impaired regulation of renal cortical oxygen consumption by nitric oxide in the aging kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Vascular endothelial dysfunction in aging: loss of Akt-dependent endothelial nitric oxide synthase phosphorylation and partial restoration by (R)-alpha-lipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Tobacco smoke is a source of toxic reactive glycation products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Oxidative stress decreases klotho expression in a mouse kidney cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Reactive oxygen species-mediated mitochondria-to-nucleus signaling: a key to aging and radical-caused diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

The role of mitochondrial superoxide anion (O2(-)) on physiological aging in C57BL/6J mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Genetic mouse models of extended lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Dwarf mice and the ageing process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

The p66shc adaptor protein controls oxidative stress response and life span in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Is the oxidative stress theory of aging dead?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Suppression of apoptosis by calorie restriction in aged kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Nuclear receptors and their coregulators in kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

An update on the lipid nephrotoxicity hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Kidney disease and cardiovascular disease: implications of dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Modified HMG-CoA reductase and LDLr regulation is deeply involved in age-related hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Hypertriglyceridemia and hepatic steatosis in senescence-accelerated mouse associate to changes in lipid-related gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Prenatal exposure to a low-protein diet programs disordered regulation of lipid metabolism in the aging rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Calorie restriction modulates renal expression of sterol regulatory element binding proteins, lipid accumulation, and age-related renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Atorvastatin reverses age-related reduction in rat hepatic PPARalpha and HNF-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Peroxisome proliferator-activated receptor-alpha deficiency protects aged mice from insulin resistance induced by high-fat diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Fenofibrate Reduces Age-related Hypercholesterolemia in Normal Rats on a Standard Diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Hepatic gene expression changes in an experimental model of accelerated senescence: the SAM-P8 mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Alterations in xenobiotic metabolism in the long-lived Little mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Nuclear hormone receptors in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Endocrine regulation of ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Aging and survival: the genetics of life span extension by dietary restriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Caloric restriction-induced life extension of rats and mice: a critique of proposed mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

A therapeutic role for sirtuins in diseases of aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Recent progress in the biology and physiology of sirtuins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Mammalian sirtuins: biological insights and disease relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

SIRT1 and caloric restriction: an insight into possible trade-offs between robustness and frailty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Tissue-specific regulation of SIRT1 by calorie restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

SirT1 regulates energy metabolism and response to caloric restriction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

SIRT1 transgenic mice show phenotypes resembling calorie restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

SirT1 gain of function increases energy efficiency and prevents diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Sirt1 protects against high-fat diet-induced metabolic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

SIRT1 deacetylates and positively regulates the nuclear receptor LXR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Metabolic benefits from Sirt1 and Sirt1 activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Caloric restriction, SIRT1 and longevity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Evidence for down-regulation of phosphoinositide 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR)-dependent translation regulatory signaling pathways in Ames dwarf mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

The TOR pathway comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Reduced TOR signaling extends chronological life span via increased respiration and upregulation of mitochondrial gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Ribosomal protein S6 kinase 1 signaling regulates mammalian life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Suppression of aging in mice by the hormone Klotho

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

A potential link between phosphate and aging--lessons from Klotho-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Regulation of ion channels by secreted Klotho: mechanisms and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Amelioration of progressive renal injury by genetic manipulation of Klotho gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Klotho is a target gene of PPAR-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Renoprotective effects of vitamin D analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Renoprotective role of the vitamin D receptor in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Transcription factor-kappa B (NF-kappa B) and renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Efficacy and safety of benazepril for advanced chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

The role of renin angiotensin system inhibition in kidney repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Antifibrotic effects of aldosterone receptor blocker (spironolactone) in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Aliskiren combined with losartan in type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Treatment of hypertension in patients 80 years of age or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Aliskiren for geriatric lowering of systolic hypertension: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Renoprotective effect of calcium channel blockers in combination with an angiotensin receptor blocker in elderly patients with hypertension. A randomized crossover trial between benidipine and amlodipine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

The significance of low HDL-cholesterol levels in an ageing society at increased risk for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Bariatric surgery and progression of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Dietary strategies for patients with type 2 diabetes in the era of multi-approaches; review and results from the Dietary Intervention Randomized Controlled Trial (DIRECT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Prevalence of chronic kidney disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Effect of lipid reduction on the progression of renal disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Short-term low calorie diet intervention reduces serum advanced glycation end products in healthy overweight or obese adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Disorders of lipid metabolism and chronic kidney disease in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Effects of the dietary approaches to stop hypertension diet alone and in combination with exercise and caloric restriction on insulin sensitivity and lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

The Okinawan diet: health implications of a low-calorie, nutrient-dense, antioxidant-rich dietary pattern low in glycemic load

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

The effects of antihypertensive therapy on carotid vascular structure in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Renal protective effect of angiotensin-converting enzyme inhibition in aging rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

L-Arginine Reduces Kidney Collagen Accumulation and N- -(carboxymethyl)lysine in the Aging NMRI-Mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Vitamin D levels and patient outcome in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

The effects of age, race and heredity on glomerular filtration rate following volume expansion and contraction in normal man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Renal function in the elderly: impact of hypertension and cardiac function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Hypertensive renovasculopathies and the rise of blood pressure with age in Japan and USA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Aging exacerbates neointimal formation, and increases proliferation and reduces susceptibility to apoptosis of vascular smooth muscle cells in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Aging and endothelial function in normotensive subjects and patients with essential hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Adaptive hyperfiltration in the aging kidney after contralateral nephrectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Age-Dependent Expression of Fibrosis-Related Genes and Collagen Deposition in Rat Kidney Cortex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Chronic on acute renal failure: long-term implications of severe acute kidney injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Pathological influence of obesity on renal structural changes in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Glomerular sclerosis in patients with massive obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Metabolic normality in overweight and obese subjects. Which parameters? Which risks?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Angiotensin II is mitogenic for cultured rat glomerular endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Effects of tetrodotoxin-induced neural inactivation on single muscle fiber metabolic enzymes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Effects of valsartan therapy on protein glycoxidation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Long-term AT1 receptor blockade improves metabolic function and provides renoprotection in Fischer-344 rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Link between angiotensin II and TGF-beta in the kidney.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

TGF-beta and regulation of interstitial nephritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

L-arginine-nitric oxide pathway and chronic nephropathy in aged rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

High glucose augments angiotensin II action by inhibiting NO synthesis in in vitro microperfused rabbit afferent arterioles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Accumulation of advanced glycation endproducts in the rat nephron: link with circulating AGEs during aging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Multiplex stress resistance in cells from long-lived dwarf mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Superoxide dismutase and glutathione peroxidase activities are increased by enalapril and captopril in mouse liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Influence of aging and calorie restriction on MAPKs activity in rat kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Dyslipidemia and the progression of renal disease in chronic renal failure patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Images in clinical medicine. Paget's disease of the mandible

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.104

Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia

31 March 2020

1 reference

12 December 2020

The klotho gene: a gene predominantly expressed in the kidney is a fundamental regulator of aging and calcium/phosphorus metabolism.

1 reference

12 December 2020

Advanced glycosylation in nephropathy of diabetes and aging

1 reference

12 December 2020

Effects of angiotensin II on cultured rat renomedullary interstitial cells are mediated by AT1A receptors

1 reference

12 December 2020

Physiological similarities and differences between renal aging and chronic renal disease.

1 reference

12 December 2020

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

1 reference

12 December 2020

1 reference

12 December 2020

Glomerular adaptations with normal aging and with long-term converting enzyme inhibition in rats

1 reference

12 December 2020

Diet and exercise in the management of hyperlipidemia.

1 reference

12 December 2020

Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription

1 reference

12 December 2020

1 reference

12 December 2020

Food restriction prevents advanced glycation end product accumulation and retards kidney aging in lean rats.

1 reference

12 December 2020

The Role of Angiotensin II in Renal Growth

1 reference

12 December 2020

Effect of weight loss after Roux-en-Y gastric bypass, on renal function and blood pressure in morbidly obese patients.

1 reference

12 December 2020

Angiotensin II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells

1 reference

12 December 2020

Vitamin E ameliorates enhanced renal lipid peroxidation and accumulation of F2-isoprostanes in aging kidneys

1 reference

12 December 2020

Glomerular hemodynamic changes associated with arteriolar lesions and tubulointerstitial inflammation.

1 reference

12 December 2020

Renal interstitial sclerosis in aging: effects of enalapril and nifedipine

1 reference

12 December 2020

Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries

1 reference

12 December 2020

Angiotensin II in renal fibrosis: should TGF-beta rather than blood pressure be the therapeutic target?

1 reference

12 December 2020

Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms

1 reference

12 December 2020

The role of lipids in renal disease: future challenges.

1 reference

12 December 2020

Decreased glomerulosclerosis in aging by angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

Overweight, obesity and metabolic alterations in chronic kidney disease

1 reference

12 December 2020

Effect of omapatrilat on the aging process of the normal rat.

1 reference

12 December 2020

Effect of chronic ANG I-converting enzyme inhibition on aging processes. I. Kidney structure and function

1 reference

12 December 2020

Down-regulation of the intrarenal renin-angiotensin system in the aging rat

1 reference

12 December 2020

Age Changes in the Human Kidney of the Different Races

1 reference

12 December 2020